Modified Glasgow Prognostic Score – a predictor of survival in malignant pleural effusion

B. Martins (Porto, Portugal), M. Serino (Porto, Portugal), P. Magalhães Ferreira (Porto, Portugal), R. Trovisco (Porto, Portugal), D. Coelho (Porto, Portugal), C. Freitas (Porto, Portugal), N. Melo (Porto, Portugal), G. Fernandes (Porto, Portugal), A. Magalhães (Porto, Portugal), H. Novais-Bastos (Porto, Portugal)

Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease
Session: Accurate diagnosis and prediction of malignant pleural disease
Session type: E-poster
Number: 3102

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Martins (Porto, Portugal), M. Serino (Porto, Portugal), P. Magalhães Ferreira (Porto, Portugal), R. Trovisco (Porto, Portugal), D. Coelho (Porto, Portugal), C. Freitas (Porto, Portugal), N. Melo (Porto, Portugal), G. Fernandes (Porto, Portugal), A. Magalhães (Porto, Portugal), H. Novais-Bastos (Porto, Portugal). Modified Glasgow Prognostic Score – a predictor of survival in malignant pleural effusion. 3102

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Contribution of PIPE Score on prognostic evaluation of idiopathic pleural effusions (IPE)
Source: International Congress 2016 – Pleural diseases
Year: 2016


LENT Score: predicting the survival of malignant pleural effusion–a prospective study of three years
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019


Karnofsky score, pH and degree of pleural involvement as prognostic factors for survival in patients with malignant pleural effusions
Source: Annual Congress 2012 - Chest wall, thoracic trauma and complications in thoracic surgery
Year: 2012


The survival prediction of malignant pleural effusion and the validation of LENT prognosis score in Thai patients.
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017


Prognostic significance of Glasgow Prognostic Score in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017



Evaluation of the Thoracic Revised Cardiac Risk Index as a prognostic factor for survival after lung cancer resection
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018

Validation of LENT and PROMISE scores in malignant pleural effusion in an Asian population
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020




Predictive parameters of survival in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


Prognostic value of treatment outcomes patients with malignant pleural mesothelioma
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010


Prognostic characteristics of malignant pleural mesothelioma
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Prognostic factors in patients with malignant pleural effusion undergoing thoracoscopy
Source: Annual Congress 2011 - From outside to inside: access to the pleura
Year: 2011

Predictors of survival in patients with recurrent malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008


Prognostic significance of neutrophil predominance in pleural fluid in patients with malignant effusion
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010


Empyema and parapneumonic pleural effusion. Prognostic factors about 109 patients
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009


The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion
Source: Eur Respir J, 55 (5) 1900980; 10.1183/13993003.00980-2019
Year: 2020



Prognostic factors in diffuse malignant pleural mesothelioma
Source: Eur Respir J 2003; 22: Suppl. 45, 62s
Year: 2003

Prognostic factors in diffuse malignant pleural mesothelioma
Source: Eur Respir J 2007; 30: Suppl. 51, 755s
Year: 2007

Malignant pleural effusion survival prognostication in an Asian population
Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Year: 2019



Therapeutic outcome and prognostic factors in patients with pleural mesothelioma
Source: Eur Respir J 2005; 26: Suppl. 49, 73s
Year: 2005